Tilray Brands, Inc.
TLRYNasdaqCIK 1731348HealthcareFiscal year ends May 31
Reports and events: 231 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0821:00 ET | 10-Q | Quarterly reportPeriod 2026-08-31 | 0001437749-26-032382 |
| 2026-10-0811:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006527 |
| 2026-09-2820:00 ET | DEF 14A | Proxy statementPeriod 2026-11-18 | 0001140361-26-037827 |
| 2026-09-1421:12 ET | 8-K | 3.02 Unregistered sale of equity | 0001140361-26-036507 |
| 2026-08-1021:00 ET | 8-K | 3.02 Unregistered sale of equity | 0001140361-26-032052 |
| 2026-07-2821:03 ET | 10-K | Annual reportPeriod 2026-05-31 | 0001437749-26-024698 |
| 2026-07-2820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004944 |
| 2026-06-3021:01 ET | 8-K | 3.02 Unregistered sale of equity | 0001140361-26-026966 |
| 2026-06-0920:31 ET | 8-K | 3.02 Unregistered sale of equity | 0001140361-26-024650 |
| 2026-04-2120:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-015921 |
| 2026-04-1512:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-014692 |
| 2026-04-1522:27 ET | 8-K | 3.02 Unregistered sale of equity | 0001140361-26-014638 |
| 2026-04-0120:30 ET | 10-Q | Quarterly reportPeriod 2026-02-28 | 0001437749-26-010907 |
| 2026-04-0111:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-002136 |
| 2026-03-0221:31 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-006389 |
| 2026-01-0822:03 ET | 10-Q | Quarterly reportPeriod 2025-11-30 | 0001437749-26-000902 |
| 2026-01-0821:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-000146 |
| 2025-11-2621:10 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-036448 |
| 2025-11-1921:30 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-035739 |
| 2025-11-1722:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-035455 |
| 2025-10-0921:12 ET | 10-Q | Quarterly reportPeriod 2025-08-31 | 0001437749-25-030797 |
| 2025-10-0911:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006368 |
| 2025-09-2621:01 ET | DEF 14A | Proxy statementPeriod 2025-11-18 | 0001140361-25-036324 |
| 2025-09-1020:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-034569 |
| 2025-07-2923:22 ET | 10-K | Annual reportPeriod 2025-05-31 | 0001437749-25-023703 |
| 2025-07-2820:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-004746 |
| 2025-06-2320:10 ET | 8-K | 3.02 Unregistered sale of equity | 0001437749-25-021037 |
| 2025-06-1021:00 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-022089 |
| 2025-04-2820:53 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001140361-25-016065 |
| 2025-04-2520:06 ET | 8-K | 3.02 Unregistered sale of equity | 0001140361-25-015720 |
| 2025-04-1711:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-012217 |
| 2025-04-0821:01 ET | 10-Q | Quarterly reportPeriod 2025-02-28 | 0001437749-25-011431 |
| 2025-04-0811:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002081 |
| 2025-03-2520:35 ET | 8-K | 3.01 Delisting notice | 0001437749-25-009162 |
| 2025-03-1021:06 ET | 8-K | 3.02 Unregistered sale of equity | 0001437749-25-006857 |
| 2025-02-2621:34 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-25-005242 |
| 2025-02-0721:31 ET | 8-K | 8.01 Other events | 0001437749-25-003171 |
| 2025-02-0621:05 ET | 8-K | 3.02 Unregistered sale of equity | 0001140361-25-003428 |
| 2025-01-1021:57 ET | 10-Q | Quarterly reportPeriod 2024-11-30 | 0001437749-25-000868 |
| 2025-01-1012:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-000152 |
| 2024-12-1921:11 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-037950 |
| 2024-12-1321:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-24-037479 |
| 2024-12-0214:01 ET | 8-K | 8.01 Other events | 0001437749-24-036395 |
| 2024-11-2121:05 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-035954 |
| 2024-11-0622:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-045431 |
| 2024-11-0120:34 ET | 8-K | 1.01 Entry into a material agreement | 0001437749-24-032999 |
| 2024-10-1013:11 ET | 10-Q | Quarterly reportPeriod 2023-08-31 | 0001437749-24-031040 |
| 2024-10-1021:05 ET | 10-Q | Quarterly reportPeriod 2024-08-31 | 0001437749-24-031042 |
| 2024-10-1011:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-005585 |
| 2024-09-2720:17 ET | DEF 14A | Proxy statementPeriod 2024-11-21 | 0001140361-24-042191 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.